The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

The conference runs from Monday through Thursday after two years of unprecedented underperformance for the healthcare sector.

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

The 43rd J.P. Morgan Healthcare Conference in San Francisco will see active participation by Korean pharmaceutical giants and ...

Erin Whaley, Tammy Ward Woffenden and Paul M. Mahoney Jr. of Troutman Pepper Locke LLP discuss key market and legal ...

This year’s J.P. Morgan Healthcare conference struck a different tone than previous years—a very pleasant one, despite higher security anxieties following the fatal shooting of ...

Kyverna Therapeutics, Inc., a leading biotechnology company focusing on autoimmune diseases, revealed its strategic priorities for the year 2025 and anticipated milestones in a recent press release on ...

As the healthcare and life sciences industry gears up for the highly anticipated JP Morgan Healthcare Conference later this ...

The first day of the JP Morgan Healthcare Conference held in San Francisco, California from 13 January to 15 January 2025 began with Johnson & Johnson, Eli Lilly and GSK announcing mergers and ...

"Being in San Francisco during the J.P. Morgan Healthcare Conference provided a valuable opportunity to engage with shareholders, innovators, and advisors in the healthcare sector," said Haimei Wu ...